THE ROLE OF DIFFUSION-WEIGHTED AND HEPATOBILIARY-PHASE MRI IN THE CHARACTERIZATION OF FOCAL LIVER LESIONS
Keywords:
focal liver lesions, magnetic resonance imaging, diffusion-weightedAbstract
Magnetic resonance imaging (MRI) offers the highest soft-tissue contrast among imaging methods and plays a central role in characterizing liver lesions that remain indeterminate after ultrasound. In recent years, diffusion-weighted imaging (DWI) and hepatobiliary contrast agents have substantially expanded the diagnostic capabilities of liver MRI. Their correct use and interpretation, including typical pitfalls, are essential for radiologists in daily practice.
Downloads
References
1. Chernyak, V., Fowler, K. J., Kamaya, A., et al. (2018). Liver Imaging Reporting and Data System (LI-RADS) version 2018: Imaging of hepatocellular carcinoma in at-risk patients. Radiology, 289(3), 816–830.
2. Grazioli, L., Bondioni, M. P., Haradome, H., et al. (2012). Hepatocellular adenoma and focal nodular hyperplasia: Value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology, 262(2), 520–529.
3. Doo, K. W., Lee, C. H., Choi, J. W., et al. (2009). "Pseudo washout" sign in high-flow hepatic hemangioma on gadoxetic acid contrast-enhanced MRI mimicking hypervascular tumor. American Journal of Roentgenology, 193(6), W490–W496.
4. Taouli, B., & Koh, D. M. (2010). Diffusion-weighted MR imaging of the liver. Radiology, 254(1), 47–66.
5. Vilgrain, V., Esvan, M., Ronot, M., et al. (2016). A meta-analysis of diffusion-weighted and gadoxetic acid-enhanced MR imaging for the detection of liver metastases. European Radiology, 26(12), 4595–4615.
